KEY FEATURES
| Full Name | Vitamin D Receptor |
|---|---|
| Synonym | NR1I1; Nuclear Receptor Subfamily 1 Group I Member 1; Calcitriol Receptor; 1,25-dihydroxyvitamin D3 receptor |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.62-40ng/mL |
| Sensitivity | 0.24ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human VDR in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human VDR. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human VDR and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human VDR, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human VDR. You can calculate the concentration of Human VDR in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human VDR ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.89 | 5.47 | 14.74 | 1.78 | 5.99 | 16.2 |
| Standard deviation | 0.1 | 0.24 | 0.55 | 0.09 | 0.29 | 0.57 |
| CV(%) | 5.08 | 4.43 | 3.73 | 5.26 | 4.8 | 3.49 |
RECOVERY
The recovery of Human VDR spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-105 | 100 |
| EDTA plasma (n=8) | 94-110 | 101 |
| Cell culture media (n=8) | 92-106 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human VDR in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with VDR ELISA Kits
| SRC ELISA Kit | publications with VDR and SRC |
| NCOA1 ELISA Kit | publications with VDR and NCOA1 |
| MED1 ELISA Kit | publications with VDR and MED1 |
| NCOR1 ELISA Kit | publications with VDR and NCOR1 |
| NCOA2 ELISA Kit | publications with VDR and NCOA2 |
| RXRA ELISA Kit | publications with VDR and RXRA |
| NCOA3 ELISA Kit | publications with VDR and NCOA3 |
| CREBBP ELISA Kit | publications with VDR and CREBBP |
| EP300 ELISA Kit | publications with VDR and EP300 |
| SNW1 ELISA Kit | publications with VDR and SNW1 |
Pathways associated with VDR ELISA Kit
| Direct P53 Effectors Pathway | Direct P53 Effectors Pathway |
| Drug Induction Of Bile Acid Pathway | Drug Induction Of Bile Acid Pathway |
| Endocrine And Other Factor-regulated Calcium Reabsorption Pathway | Endocrine And Other Factor-regulated Calcium Reabsorption Pathway |
| Gene Expression Pathway | Gene Expression Pathway |
| Generic Transcription Pathway | Generic Transcription Pathway |
| Mineral Absorption Pathway | Mineral Absorption Pathway |
| Nuclear Receptor Transcription Pathway | Nuclear Receptor Transcription Pathway |
| Nuclear Receptors Pathway | Nuclear Receptors Pathway |
Diseases associated with VDR ELISA Kit
| Osteoporosis | publications with VDR and Osteoporosis |
| Vitamin D Deficiency | publications with VDR and Vitamin D Deficiency |
| Kidney Diseases | publications with VDR and Kidney Diseases |
| Breast Neoplasms | publications with VDR and Breast Neoplasms |
| Rickets | publications with VDR and Rickets |
| Inflammation | publications with VDR and Inflammation |
| Prostatic Neoplasms | publications with VDR and Prostatic Neoplasms |
| Cardiovascular Diseases | publications with VDR and Cardiovascular Diseases |
| Hypercalcemia | publications with VDR and Hypercalcemia |
| Genetic Diseases, Inborn | publications with VDR and Genetic Diseases, Inborn |
Organs/Tissues associated with VDR ELISA Kit
| Bone | publications with VDR and Bone |
| Connective Tissue | publications with VDR and Connective Tissue |
| Heart | publications with VDR and Heart |
| Muscle | publications with VDR and Muscle |
| Brain | publications with VDR and Brain |
| Vascular | publications with VDR and Vascular |
| Embryonic Tissue | publications with VDR and Embryonic Tissue |
| Ear | publications with VDR and Ear |
| Kidney | publications with VDR and Kidney |
| Umbilical Cord | publications with VDR and Umbilical Cord |